# Ulinastatin in Inhalation Lung Injury

> **NCT01287806** · PHASE2 · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Inhalation Injury

## Interventions

- **DRUG:** ulinastatin
- **DRUG:** blank group

## Key facts

- **NCT ID:** NCT01287806
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-02
- **Primary completion:** 2012-12
- **Final completion:** 2013-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2011-02-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01287806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01287806, "Ulinastatin in Inhalation Lung Injury". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01287806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*